Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dolby Laboratories (DLB) Capital Expenditures (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Capital Expenditures for 17 consecutive years, with $4.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 31.73% year-over-year to $4.6 million, compared with a TTM value of $34.2 million through Dec 2025, up 11.44%, and an annual FY2025 reading of $36.3 million, up 21.13% over the prior year.
  • Capital Expenditures was $4.6 million for Q4 2025 at Dolby Laboratories, down from $16.2 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $16.2 million in Q3 2025 and bottomed at $4.6 million in Q4 2025.
  • Average Capital Expenditures over 5 years is $9.4 million, with a median of $7.9 million recorded in 2023.
  • The sharpest move saw Capital Expenditures plummeted 50.06% in 2022, then skyrocketed 120.14% in 2025.
  • Year by year, Capital Expenditures stood at $14.5 million in 2021, then tumbled by 50.06% to $7.2 million in 2022, then fell by 15.49% to $6.1 million in 2023, then rose by 11.15% to $6.8 million in 2024, then tumbled by 31.73% to $4.6 million in 2025.
  • Business Quant data shows Capital Expenditures for DLB at $4.6 million in Q4 2025, $16.2 million in Q3 2025, and $6.4 million in Q2 2025.